EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Src inhibition modulates AMBRA1 ‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis

Zeping Gui iD, Xuzhong Liu, Zhen Xu, Dengyuan Feng, Zhou Hang, Ming Zheng, Hao Chen, Shuang Fei, Li Sun, Jun Tao, Zhijian Han, Xiaobin Ju and 3 more

Cell Proliferation · 2024

DOI: 10.1111/cpr.13699 ↗

At a glance

Journal article in Cell Proliferation, 2024. Written by Zeping Gui and 14 co-authors. Institution: Department of Urology, The Second Affiliated Hospital with Nanjing Medical University, Nanjing, China. Major MEDLINE topics: Mitophagy, Fibrosis, Kidney Transplantation, src-Family Kinases. Cited 11 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: Jiangsu Province Natural Science Foundation Program, "333 High Level Talents Project" in Jiangsu Province, Xuzhou Medical University Outstanding Talents Fund Project.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Chronic allograft dysfunction (CAD) poses a significant challenge in kidney transplantation, with renal vascular endothelial‐to‐mesenchymal transition (EndMT) playing a vital role. While renal vascular EndMT has been verified as an important contributing factor to renal allograft interstitial fibrosis/tubular atrophy in CAD patients, its underlying mechanisms remain obscure. Currently, Src activation is closely linked to organ fibrosis development. Single‐cell transcriptomic analysis in clinical patients revealed that Src is a potential pivotal mediator in CAD progression. Our findings revealed a significant upregulation of Src which closely associated with EndMT in CAD patients, allogeneic kidney transplanted rats and endothelial cells lines. In vivo, Src inhibition remarkably alleviate EndMT and renal allograft interstitial fibrosis in allogeneic kidney transplanted rats. It also had a similar antifibrotic effect in two endothelial cell lines. Mechanistically, the knockout of Src resulted in an augmented AMBRA1‐mediated mitophagy in endothelial cells. We demonstrate that Src knockdown upregulates AMBRA1 level and activates mitophagy by stabilizing Parkin's ubiquitination levels and mitochondrial translocation. Subsequent experiments demonstrated that the knockdown of the Parkin gene inhibited mitophagy in endothelial cells, leading to increased production of Interleukin‐6, thereby inducing EndMT. Consequently, our study underscores Src as a critical mediator of renal vascular EndMT and allograft interstitial fibrosis, exerting its impact through the regulation of AMBRA1/Parkin‐mediated mitophagy.

Subjects

MeSH terms (MEDLINE)

MitophagyFibrosisKidney Transplantationsrc-Family KinasesAnimalsRatsHumansMaleAdaptor Proteins, Signal TransducingAllograftsKidneyEpithelial-Mesenchymal TransitionUbiquitin-Protein LigasesEndothelial Cells

Substances

src-Family KinasesAdaptor Proteins, Signal TransducingUbiquitin-Protein Ligasesparkin protein

Authors and institutions

  • Department of Urology, The Second Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Department of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Department of Urology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.
  • Department of Urology, Affiliated Clinical College of Xuzhou Medical University, Huai'an, China.
  • Department of Urology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.

ORCID profiles: Zeping Gui

Funding

  • Jiangsu Province Natural Science Foundation Program
  • "333 High Level Talents Project" in Jiangsu Province
  • Xuzhou Medical University Outstanding Talents Fund Project
  • Huaian First People's Hospital High-level Talent Project
  • National Natural Science Foundation of China
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province

Cite

APA

Gui, Z., Liu, X., Xu, Z., Feng, D., Hang, Z., Zheng, M., Chen, H., Fei, S., Sun, L., Tao, J., Han, Z., Ju, X., Gu, M., Tan, R., & Wang, Z. (2024). Src inhibition modulates AMBRA1 ‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis. Cell Proliferation. https://doi.org/10.1111/cpr.13699

Vancouver

Gui Z, Liu X, Xu Z, Feng D, Hang Z, Zheng M, et al. Src inhibition modulates AMBRA1 ‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis. Cell Proliferation. 2024. doi:10.1111/cpr.13699

BibTeX
@article{Gui2024,
  author = {Gui, Zeping and Liu, Xuzhong and Xu, Zhen and Feng, Dengyuan and Hang, Zhou and Zheng, Ming and Chen, Hao and Fei, Shuang and Sun, Li and Tao, Jun and Han, Zhijian and Ju, Xiaobin and Gu, Min and Tan, Ruoyun and Wang, Zijie},
  title = {Src inhibition modulates AMBRA1 ‐mediated mitophagy to counteract endothelial‐to‐mesenchymal transition in renal allograft fibrosis},
  journal = {Cell Proliferation},
  year = {2024},
  doi = {10.1111/cpr.13699}
}
Start for free →